This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Home Dialysis Patients Featured At Innovative Dialysis Home Dialysis Meeting

LONG BEACH, Calif., Nov. 6, 2012 /PRNewswire/ -- Representatives of over 30 home dialysis programs operated by  Innovative Dialysis Systems gathered in Long Beach, CA recently, for the company's first Home Dialysis Employee Retreat. 

"Home dialysis nurses have a unique role in our dialysis centers, and they don't always have the opportunity to network with their peers to share ideas and experiences," said Anita Lipman, National Director of Home Therapies for Innovative Dialysis.  "This meeting was a chance for these nurses to be recognized for the important work that they do, to learn more about home therapy options, and to share their own personal stories with the group."

Representatives of companies that provide home dialysis equipment, products and supplies made presentations to the attendees.  Baxter Healthcare and NxStage Medical, the current leaders in home dialysis equipment, were supporters of the meeting.  Affymax and Metro Medical Systems also attended and provided enthusiasm and education to the group.

The home dialysis program nurses were introduced to Innovative Dialysis' new patient education program, called "Innovative Choices," a free class for Chronic Kidney Disease (CKD) patients and their families that is designed to help them understand the disease and their treatment options better. 

Participants agreed that the highlight of the meeting was the patient panel.  Local home dialysis patients Sandra Peoples, of Westside Dialysis Center in Los Angeles, and Don Tsunawaki, of West Coast Dialysis in Long Beach, CA, shared the stage and their home dialysis experience with the audience.

Both speakers stressed that Chronic Kidney Disease patients need to understand that they have choices when it comes to their eventual dialysis care.  "Patients need to be informed.  They need to know that there are options for End Stage Renal Disease care.  I didn't know what questions to ask, and I don't think a lot of other patients know either," said Ms. Peoples.  

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs